Non-targeted effects (NTE) have been generally regarded as a low-dose ionizing radiation
(IR) phenomenon. Recently, regarding long distant abscopal effects have also been …

Cancer immunotherapy moderates the immune system's ability to fight cancer. Due to its
extreme complexity, scientists are working to put together all the puzzle pieces to get a …

Breast cancer is a complex disease exhibiting a great degree of heterogeneity due to
different molecular subtypes. Notch signaling regulates the differentiation of breast epithelial …

Identifying the phenotype of aggressive breast cancer (BC) cells is vital for the effectiveness
of surgical intervention and standard-of-care therapy. HER-2 is overexpressed in aggressive …

Breast cancer remains a leading global cause of morbidity and mortality. While the field of
immunotherapy is a promising avenue of investigation and has revolutionized the standard …

Invasive ductal carcinoma (IDC) is the most common histological subtype of malignant
breast cancer (BC), and accounts for 70–80% of all invasive BCs. IDC demonstrates great …

Breast cancer is the most common cancer in women. It is a heterogeneous disease,
encompassing different biological subtypes that differ in histological features, outcomes …

Known as a diverse collection of neoplastic diseases, breast cancer (BC) can be
hyperbolically characterized as a dynamic pseudo-organ, a living organism able to build a …

Expression of the cell surface heparan sulfate proteoglycan syndecan-4 is dysregulated in
breast cancer, the most frequent malignancy in women. High expression of syndecan-4 …

Data from globocan statistic in 2020 indicate that breast cancer has become highest
incidence rate of cancer. Estrogen receptor (ER), progesterone receptor (PR) and human …